Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Pugliese

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Biorxiv : the Preprint Server for Biology|July 28, 2023
Macrophage Xanthine Oxidoreductase Links LPS Induced Lung Inflammatory Injury to NLRP3 Inflammasome Expression and Mitochondrial RespirationMehdi A Fini, Jenifer A Monks, Min Li, et al.
Cardiovascular Research|November 12, 2019
Interstitial macrophage-derived thrombospondin-1 contributes to hypoxia-induced pulmonary hypertensionRahul Kumar, Claudia Mickael, Biruk Kassa, et al.
Annals of the American Thoracic Society|December 22, 2021
Secular and Regional Trends among Pulmonary Arterial Hypertension Clinical Trial ParticipantsJeff Min, Dina H Appleby, Robyn L McClelland, et al.
Chest|November 29, 2024
Epicardial Adipose Tissue as an Independent Risk Factor for Mortality in Pulmonary Arterial HypertensionBreanne E McCarthy, Rui Feng, Drew A Torigian, et al.
The European Respiratory Journal|September 14, 2019
Suppression of HIF2 signalling attenuates the initiation of hypoxia-induced pulmonary hypertensionCheng-Jun Hu, Jens M Poth, Hui Zhang, et al.
Chest|March 5, 2022
BMI and Treatment Response in Patients With Pulmonary Arterial Hypertension: A Meta-analysisBreanne E McCarthy, Robyn L McClelland, Dina H Appleby, et al.
Heart (British Cardiac Society)|February 14, 2023
Pulmonary artery compliance in different forms of pulmonary hypertensionAmber McCormick, Amita Krishnan, David Badesch, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 2014
Adventitial fibroblasts induce a distinct proinflammatory/profibrotic macrophage phenotype in pulmonary hypertensionKarim C El Kasmi, Steven C Pugliese, Suzette R Riddle, et al.
Pulmonary Circulation|October 21, 2021
Health-related quality of life and hospitalizations in chronic thromboembolic pulmonary hypertension versus idiopathic pulmonary arterial hypertension: an analysis from the Pulmonary Hypertension Association Registry (PHAR)Jasleen Minhas, Sai Prasanna Narasimmal, Todd M Bull, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 19, 2001
SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivoJ M Strizki, S Xu, N E Wagner, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Biorxiv : the Preprint Server for Biology|July 28, 2023
Macrophage Xanthine Oxidoreductase Links LPS Induced Lung Inflammatory Injury to NLRP3 Inflammasome Expression and Mitochondrial RespirationMehdi A Fini, Jenifer A Monks, Min Li, et al.
Cardiovascular Research|November 12, 2019
Interstitial macrophage-derived thrombospondin-1 contributes to hypoxia-induced pulmonary hypertensionRahul Kumar, Claudia Mickael, Biruk Kassa, et al.
Annals of the American Thoracic Society|December 22, 2021
Secular and Regional Trends among Pulmonary Arterial Hypertension Clinical Trial ParticipantsJeff Min, Dina H Appleby, Robyn L McClelland, et al.
Chest|November 29, 2024
Epicardial Adipose Tissue as an Independent Risk Factor for Mortality in Pulmonary Arterial HypertensionBreanne E McCarthy, Rui Feng, Drew A Torigian, et al.
The European Respiratory Journal|September 14, 2019
Suppression of HIF2 signalling attenuates the initiation of hypoxia-induced pulmonary hypertensionCheng-Jun Hu, Jens M Poth, Hui Zhang, et al.
Chest|March 5, 2022
BMI and Treatment Response in Patients With Pulmonary Arterial Hypertension: A Meta-analysisBreanne E McCarthy, Robyn L McClelland, Dina H Appleby, et al.
Heart (British Cardiac Society)|February 14, 2023
Pulmonary artery compliance in different forms of pulmonary hypertensionAmber McCormick, Amita Krishnan, David Badesch, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 2014
Adventitial fibroblasts induce a distinct proinflammatory/profibrotic macrophage phenotype in pulmonary hypertensionKarim C El Kasmi, Steven C Pugliese, Suzette R Riddle, et al.
Pulmonary Circulation|October 21, 2021
Health-related quality of life and hospitalizations in chronic thromboembolic pulmonary hypertension versus idiopathic pulmonary arterial hypertension: an analysis from the Pulmonary Hypertension Association Registry (PHAR)Jasleen Minhas, Sai Prasanna Narasimmal, Todd M Bull, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 19, 2001
SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivoJ M Strizki, S Xu, N E Wagner, et al.
Pageof 8